Europe's most focused gathering of life sciences dealmakers. Two intensive days of high-calibre deal conversations, curated 1:1 partnering sessions, expert-led panels, and the commercial intelligence that drives licensing, M&A, and strategic partnerships across the global biopharma landscape.
The BioPharma Deals Conference is the gathering point for the Pharma Biotech dealmakers to initiate, advance, and close deals.
This is not a general pharma congress. It is an exclusive, targeted and BD&L focused summit where every session, every meeting, and every curated interaction is designed with a potential to generate real commercial outcomes, licensing agreements, co-development mandates, investment conversations, and strategic partnerships that reshape pipelines.
Every session, break, and reception is engineered to create deal momentum and meaningful commercial connection.
Industry leaders who have shared their deal-making expertise at BioPharma Deals summits. Every speaker holds a real BD&L role and brings current, unfiltered market intelligence.
Major keynotes from Chief BD Officers and senior dealmakers at global pharma, covering the topics that define BD&L strategy in 2026 — valuations, therapy areas, deal structure, and market outlook.
500+ pre-scheduled bilateral meetings arranged via the conference platform. Each meeting is 20 minutes, pre-screened for mutual relevance, and scheduled to maximise your deal pipeline return from both days.
Curated panel debates featuring Chief BD Officers, General Counsels, investors, and licensing veterans on the toughest deal challenges: term sheet structuring, cross-border complexity, valuation disputes, and post-deal governance.
Structured pipeline presentations where companies present assets directly to an audience of active in-licensors, corporate development leaders, and investors. Followed by facilitated introductions.
Two intensive half-day masterclasses — Due Diligence Excellence and Alliance Management — led by advisors with decades of life sciences transactional experience. Practical frameworks, real case studies, zero theory.
Hosted cocktail reception on Day 1 evening, with curated dinner tables by therapy area and deal type. The informal settings where the most candid deal conversations happen and relationships are built for years to come.
Munich sits at the heart of Europe's most dynamic life sciences cluster. Home to global pharma operations, a thriving biotech ecosystem, and exceptional international connectivity, it is the natural home for Europe's premier BD&L Summit.
"Euronext is a pan-European stock exchange, with a special focus on life sciences. I attended the Pharma Partnering Summit in Brussels and was delighted to share a wealth of details, statistics, and data about Euronext and the opportunities for companies to go public. The response was positive, and I would be glad to come back!"
"I am from the UK's Department for Business and Trade. I'm very impressed with the kinds of speakers that were presenting today and the calibre of folks that are in attendance. I would highly recommend anyone who's from small Pharma or big Pharma to come out and try to find partnerships for your future endeavours. Thank you."
"The meetings actually turned out to be quite surprising, with some good lead generation. In all of these, I've been quite surprised, quite frankly. It’s my first time participating in this event, and I discovered a set of companies I hadn’t really heard of before. Today, I realised they have interesting assets that could be ready for licensing."
"I think the thing that stuck out to me was the level of openness and generosity of everyone to really share their experiences across all aspects of partnering in licensing, out licensing, the whole arena really. So a really amazing opportunity to interact with others in the breaks, as well as the formal networking platform, which was a fantastic way to really meet those you wanted to."
"I’m very pleased to see such a diverse group of business partners here, ranging from small and medium enterprises to R&D organisations, not-for-profit NGOs, and, of course, big pharma. It’s a great platform for me to connect with various business leaders and explore potential deals."
"It's a great place to meet with peers in the industry in the BD field, from big multinational companies to midsize companies to biotech companies. I'm very happy to be here to connect with people and looking forward to participating in more meetings as such in the future."
"I had the opportunity to engage with a variety of speakers from both big pharma and smaller companies, as well as suppliers and CDMOs. I particularly appreciated the diverse panels and topics that are all relevant to us. This was one of the first live meetings again in the heart of Europe, which I really enjoyed. Additionally, we had the chance to make new connections during the partnering events in the afternoon. I greatly appreciate this experience and look forward to the next edition!"
"I really enjoyed the venue in Brussels and talks were interesting. Enjoyed networking, Looking forward to Join future Conference."
"It was a great conference that we had. I was able to meet a lot of people from the pharmaceutical industry, as well as other people that we can potentially partner with, and I was really impressed by the level of seniority of the attendees from the pharma industry. That's something that was great, it was an intimate setting here. We got to have a lot of face time, so I couldn't be happier with how it turned out. Thanks a lot."
"I'm attending this conference to meet potential partners interested in licensing or acquiring our products. I have to say that the audience here is ideal for my goals. I've had plenty of pre-scheduled meetings and find this event to be highly valuable."
"Conferences were relevant and I met very interesting people and continuing conversation with some."
"To my great surprise, it was unbelievably good because the quality of the participants was highly selective, which is the secret to meetings like this one. I’m quite happy to be going back to Paris with a full pocket."
"We are a California Armenia based biometric CRO. Partnering with Summit has provided us with an excellent opportunity to connect with both our existing partners and potential new ones. It's a fantastic opportunity to engage with colleagues and raise awareness about what we do and what we seek."
"We came to this Pharma Partnering Summit to reconnect with clients after a long time and to meet new ones. We've enjoyed the opportunity for many discussions over coffee and spontaneous conversations, which have been quite dynamic."
"Thank you for this great event! It was an interesting opportunity to meet some qualified leads. I'm also looking forward to next edition."
"We have been in a Pharma Partnering Summit this year to meet different companies around pharma value chain it has been fantastic opportunity to meet lot of people and to make some valuable connections."
"It’s great to be at the summit, where I’ve had the chance to meet many industry professionals and discuss our new innovative model. This event has allowed us to identify collaboration opportunities, generate leads, and hopefully partner with others to bring innovative therapies to market in the coming year."
"It’s truly exciting to be surrounded by professionals from the pharmaceutical industry, biotech, and other healthcare-related fields. I’m particularly eager to hear about new ideas and innovations happening in this space, especially in Boston and the Northeast, which is unmatched anywhere else in the U.S. As an intellectual property attorney, I find it invaluable to engage with these fresh perspectives and developments."
We apply a rigorous curation process to ensure every attendee holds genuine deal authority. No passengers — every person in the room can initiate and advance a real deal.
Senior BD leaders from Big Pharma, Specialty Pharma, and mid-sized biopharmaceuticals responsible for licensing and partnership strategy at portfolio level.
Licensing · PartneringLeaders of innovative biotech companies at Series B through commercial stage, actively seeking licensing partners, co-development agreements, and strategic acquirers.
Out-Licensing · FundraisingVenture capitalists, family offices, and corporate venture arms deploying capital across early and late-stage assets, evaluating in-licensing and co-investment structures.
Venture · Corporate VentureDeal execution professionals responsible for structuring, negotiating, and closing licensing agreements — from term sheet through contract and ongoing alliance management.
Execution · Alliance MgmtCorporate development directors and M&A advisors running buy-side and sell-side mandates across pharma, biotech, medtech, and diagnostics.
M&A · Corporate DevSpecialist advisors — transactional lawyers, IP counsel, investment bankers, and financial due diligence experts — who bring deals to fruition and protect value through execution.
Legal · IP · FinancePlaces are limited and pre-vetted. All registrations are reviewed before confirmation to ensure the quality and seniority of the delegate community.
Complete individual conference experience with full access to all sessions and networking opportunities.
Special pricing for teams of two. Ideal for companies sending multiple representatives to maximise their conference ROI.
Enhanced savings for larger teams. Perfect for companies bringing their entire business development team.
A 15-minute presentation opportunity to introduce your assets, services, platform, and technology to potential partners.
Amplify your company's reach with a prime-time presentation slot showcasing your assets and innovative solutions.
Promote your products, brand, and solutions from a 10×10 exhibition space to industry leaders.
Maximise your exhibition impact with enhanced capacity to promote your complete portfolio.
The ultimate package for maximum impact. Combine a dedicated 10×10 exhibition space with a 15-minute prime-time stage presentation.
Your logo prominently displayed on WiFi access materials throughout the venue.
Your logo on every attendee's lanyard for continuous two-day visibility.
Your logo on every attendee's name badge. Ensures your brand is seen throughout every handshake.
Sponsor the water stations and associate your brand with sustainability.
Sponsor the coffee breaks and get your brand in front of all attendees during key networking moments.
Premium sponsorship with your brand associated with the main lunch event. Maximum visibility.
An intensive 2-day training course led by industry experts with 35+ years of deal-making experience. Choose the access level that best fits your networking and learning goals.
Perfect for professionals focused purely on upskilling. Includes 2-day access to all core training modules, course materials, and certification.
Combine your learning with the main summit. Get 2-day access to the conference, all training modules, and full catering including lunch.
The ultimate package for deal-makers. Includes full conference, training, 1:1 meeting access, pre-arranged meetings, and premium branding visibility.
Join Europe's most focused gathering of BD&L professionals. Two days. One shared ambition: to close the deals that advance the science of life.